{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:51:44Z","timestamp":1790092304180,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Zhejiang Provincial Natural Science Foundation of China","award":["program number: LY18H160035"],"award-info":[{"award-number":["program number: LY18H160035"]}]},{"name":"the Zhejiang Province Medical and Health Care Project","award":["2019KY279"],"award-info":[{"award-number":["2019KY279"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The relationship between total lymphocyte counts (TLCs) and survival is not well documented in rectal cancer. This study aimed to investigate the association between TLCs and disease-free survival (DFS) and identify factors associated with lymphopenia in locally advanced rectal cancer patients receiving chemoradiotherapy. Thirty-six patients with locally advanced rectal cancer were retrospectively analyzed. TLCs were evaluated before surgery (pre-S), before radiotherapy (pre-RT), and during concurrent chemoradiotherapy (CCRT). The relationship between TLCs and DFS was analyzed by univariate and multivariate analysis. Potential clinical factors associated with lymphopenia were also evaluated. Median TLC declined significantly during radiotherapy. Severe lymphopenia during CCRT was significantly associated with poorer DFS on Kaplan\u2013Meier analysis (p\u2009=\u20090.01), univariate regression analysis (p\u2009=\u20090.036), and multivariate regression analysis (p\u2009=\u20090.038). Pre-S TLCs (p\u2009=\u20090.009) and pre-RT TLCs (p\u2009=\u20090.042) were significantly associated with severe lymphopenia on univariate regression analysis; however, only pre-S TLCs (p\u2009=\u20090.026) were significantly associated with severe lymphopenia on multivariate regression analysis. Severe lymphopenia was a predictor of poorer DFS in patients with locally advanced rectal cancer receiving adjuvant chemoradiotherapy. Pre-S TLCs were predictors of severe lymphopenia. Further study is warranted to reduce the rate of severe lymphopenia.<\/jats:p>","DOI":"10.1038\/s41598-023-34145-4","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:02:17Z","timestamp":1683702137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Severe lymphopenia as a prognostic factor in rectal cancer patients receiving adjuvant chemoradiotherapy: a retrospective study"],"prefix":"10.1038","volume":"13","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"34145_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"34145_CR2","first-page":"1130","volume":"84","author":"KM Tveit","year":"1997","unstructured":"Tveit, K. M. et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br. J. Surg. 84, 1130\u20131135 (1997).","journal-title":"Br. J. Surg."},{"key":"34145_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer, R. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351, 1731\u20131740 (2004).","journal-title":"N. Engl. J. Med."},{"key":"34145_CR4","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"27","author":"MS Roh","year":"2009","unstructured":"Roh, M. S. et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J. Clin. Oncol. 27, 5124\u20135130 (2009).","journal-title":"J. Clin. Oncol."},{"key":"34145_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","volume":"18","author":"W Ngwa","year":"2018","unstructured":"Ngwa, W. et al. Using immunotherapy to boost the abscopal effect. Nat. Rev. Cancer 18, 313\u2013322 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"34145_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00280-011-1610-3","volume":"68","author":"N Ceze","year":"2011","unstructured":"Ceze, N. et al. Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother. Pharmacol. 68, 1305\u20131313 (2011).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"34145_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2407-11-64","volume":"11","author":"J Kitayama","year":"2011","unstructured":"Kitayama, J., Yasuda, K., Kawai, K., Sunami, E. & Nagawa, H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer 11, 64 (2011).","journal-title":"BMC Cancer"},{"key":"34145_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4143\/crt.2014.351","volume":"48","author":"J Heo","year":"2016","unstructured":"Heo, J. et al. Sustaining blood lymphocyte count during preoperative chemoradiotherapy as a predictive marker for pathologic complete response in locally advanced rectal cancer. Cancer Res. Treat. 48, 232\u2013239 (2016).","journal-title":"Cancer Res. Treat."},{"key":"34145_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","volume":"89","author":"C Tang","year":"2014","unstructured":"Tang, C. et al. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. Int. J. Radiat. Oncol. Biol. Phys. 89, 1084\u20131091 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"34145_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","volume":"99","author":"R Davuluri","year":"2017","unstructured":"Davuluri, R. et al. Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 99, 128\u2013135 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"34145_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijrobp.2007.09.024","volume":"71","author":"CH Choi","year":"2008","unstructured":"Choi, C. H. et al. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Int. J. Radiat. Oncol. Biol. Phys. 71, 199\u2013204 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"34145_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canep.2013.12.008","volume":"38","author":"LC Peng","year":"2014","unstructured":"Peng, L. C. et al. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer. Cancer Epidemiol. 38, 73\u201378 (2014).","journal-title":"Cancer Epidemiol."},{"key":"34145_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s13277-015-3888-y","volume":"37","author":"O Cho","year":"2016","unstructured":"Cho, O., Oh, Y. T., Chun, M., Noh, O. K. & Lee, H. W. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer. Tumour Biol. 37, 971\u2013978 (2016).","journal-title":"Tumour Biol."},{"key":"34145_CR14","first-page":"094","volume":"2021","author":"T Sumiya","year":"2021","unstructured":"Sumiya, T. et al. The impact of lymphopenia during chemoradiotherapy using photons or protons on the clinical outcomes of esophageal cancer patients. J. Radiat. Res. 2021, 094 (2021).","journal-title":"J. Radiat. Res."},{"key":"34145_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/07357907.2012.700987","volume":"30","author":"A Balmanoukian","year":"2012","unstructured":"Balmanoukian, A., Ye, X., Herman, J., Laheru, D. & Grossman, S. A. The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas. Cancer Investig. 30, 571\u2013576 (2012).","journal-title":"Cancer Investig."},{"key":"34145_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/07357907.2013.767342","volume":"31","author":"JL Campian","year":"2013","unstructured":"Campian, J. L., Ye, X., Brock, M. & Grossman, S. A. Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer. Cancer Investig. 31, 183\u2013188 (2013).","journal-title":"Cancer Investig."},{"key":"34145_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/COC.0b013e3182940ff9","volume":"38","author":"AT Wild","year":"2015","unstructured":"Wild, A. T. et al. The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma. Am. J. Clin. Oncol. 38, 259\u2013265 (2015).","journal-title":"Am. J. Clin. Oncol."},{"key":"34145_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/hed.23535","volume":"36","author":"JL Campian","year":"2014","unstructured":"Campian, J. L., Sarai, G., Ye, X., Marur, S. & Grossman, S. A. Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer. Head Neck 36, 1747\u20131753 (2014).","journal-title":"Head Neck"},{"key":"34145_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","volume":"94","author":"AT Wild","year":"2016","unstructured":"Wild, A. T. et al. Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 94, 571\u2013579 (2016).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"34145_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamcollsurg.2013.04.018","volume":"217","author":"DM Hari","year":"2013","unstructured":"Hari, D. M. et al. AJCC cancer staging manual 7th edition criteria for colon cancer: Do the complex modifications improve prognostic assessment? J. Am. Coll. Surg. 217, 181\u201390 (2013).","journal-title":"J. Am. Coll. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34145-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:07:26Z","timestamp":1683702446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34145-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34145"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34145-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2268490\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"13 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7566"}}